课题基金 / 基金详情

项目摘要

项目成果

JOSEPH P. UBERTI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DEVELOPMENTAL FUNDS – ABSTRACT Developmental Funds at KCI provide an important and essential source of funds in support of the Cancer Center’s investment in strategic initiatives. These initiatives are formalized through extensive planning and evaluation processes. During the past funding period, CCSG Developmental Funds were used in two key areas; 1) the recruitment of a key investigator in a Program leadership role, and 2) support of strategic pilot projects. CCSG funds were significantly augmented by institutional support to further recruitment efforts and provide funds for pilot projects aligned with KCI’s strategic priorities. Specifically, during the current grant cycle (12/1/2015 to 11/30/2019), $214,813 of CCSG Developmental Funds was augmented by an additional $14.8 million of institutional support to provide valuable support for 51 pilot projects consistent with the strategic vision of KCI and the recruitment of 36 new faculty, including 11 early stage investigators. The completed pilot projects have resulted in a five-fold return on investment measured by success in obtaining peer reviewed extramural funding. Additionally, new faculty level scientists have published 226 peer reviewed articles, secured 59 grant awards, and activated 129 clinical trials since their arrival. CCSG Developmental Funds in the amount of $55,550 are requested to fund pilot projects in the five areas of the Cancer Center’s focused future development. CCSG Developmental Funds, invested in pilot projects and augmented with institutional funding, have successfully driven innovative research and have led to extramurally funded projects over the course of the current grant cycle. This trend is expected to continue into the years to come, as KCI pursues the goals established in the strategic plan and engages with community partners to develop innovative projects that address the specific needs of the catchment area.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
P30 Admin Sup to Enhance (SOGI) Data Collection
  • 批准号:
    10642438
  • 项目类别:
  • 资助金额:
    $14.99万
  • 财政年份:
    2022
  • 负责人:
    JOSEPH P. UBERTI
  • 依托单位:
Administrative Supplements for NCI P30 Cancer Center Support Grants The Early Drug Development Opportunity Program (EDDOP)
  • 批准号:
    10677088
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2022
  • 负责人:
    JOSEPH P. UBERTI
  • 依托单位:
CANCER CENTER SUPPORT GRANT
  • 批准号:
    10348659
  • 项目类别:
  • 资助金额:
    $263.68万
  • 财政年份:
    1997
  • 负责人:
    JOSEPH P. UBERTI
  • 依托单位:
Shared Resource Management
  • 批准号:
    10348669
  • 项目类别:
  • 资助金额:
    $127.59万
  • 财政年份:
    1997
  • 负责人:
    JOSEPH P. UBERTI
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: